These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

883 related articles for article (PubMed ID: 11606380)

  • 1. Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.
    Bhat KP; Lantvit D; Christov K; Mehta RG; Moon RC; Pezzuto JM
    Cancer Res; 2001 Oct; 61(20):7456-63. PubMed ID: 11606380
    [TBL] [Abstract][Full Text] [Related]  

  • 2. 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells.
    Ramamoorthy K; Gupta MS; Sun G; McDougal A; Safe SH
    Carcinogenesis; 1999 Jan; 20(1):115-23. PubMed ID: 9934858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Resveratrol exhibits cytostatic and antiestrogenic properties with human endometrial adenocarcinoma (Ishikawa) cells.
    Bhat KP; Pezzuto JM
    Cancer Res; 2001 Aug; 61(16):6137-44. PubMed ID: 11507064
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9.
    Banerjee S; Bueso-Ramos C; Aggarwal BB
    Cancer Res; 2002 Sep; 62(17):4945-54. PubMed ID: 12208745
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Resveratrol enhances the chemopreventive effect of celecoxib in chemically induced breast cancer in rats.
    Kisková T; Jendželovský R; Rentsen E; Maier-Salamon A; Kokošová N; Papčová Z; Mikeš J; Orendáš P; Bojková B; Kubatka P; Svoboda M; Kajo K; Fedoročko P; Jäger W; Ekmekcioglu C; Kassayová M; Thalhammer T
    Eur J Cancer Prev; 2014 Nov; 23(6):506-13. PubMed ID: 25254309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential cancer-chemopreventive activities of wine stilbenoids and flavans extracted from grape (Vitis vinifera) cell cultures.
    Waffo-Téguo P; Hawthorne ME; Cuendet M; Mérillon JM; Kinghorn AD; Pezzuto JM; Mehta RG
    Nutr Cancer; 2001; 40(2):173-9. PubMed ID: 11962253
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A combination of resveratrol and melatonin exerts chemopreventive effects in N-methyl-N-nitrosourea-induced rat mammary carcinogenesis.
    Kisková T; Ekmekcioglu C; Garajová M; Orendáš P; Bojková B; Bobrov N; Jäger W; Kassayová M; Thalhammer T
    Eur J Cancer Prev; 2012 Mar; 21(2):163-70. PubMed ID: 22044852
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TAS-108, a novel oral steroidal antiestrogenic agent, is a pure antagonist on estrogen receptor alpha and a partial agonist on estrogen receptor beta with low uterotrophic effect.
    Yamamoto Y; Shibata J; Yonekura K; Sato K; Hashimoto A; Aoyagi Y; Wierzba K; Yano S; Asao T; Buzdar AU; Terada T
    Clin Cancer Res; 2005 Jan; 11(1):315-22. PubMed ID: 15671561
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways.
    Singh B; Shoulson R; Chatterjee A; Ronghe A; Bhat NK; Dim DC; Bhat HK
    Carcinogenesis; 2014 Aug; 35(8):1872-80. PubMed ID: 24894866
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prepubertal estradiol and genistein exposures up-regulate BRCA1 mRNA and reduce mammary tumorigenesis.
    Cabanes A; Wang M; Olivo S; DeAssis S; Gustafsson JA; Khan G; Hilakivi-Clarke L
    Carcinogenesis; 2004 May; 25(5):741-8. PubMed ID: 14729590
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dietary genistein results in larger MNU-induced, estrogen-dependent mammary tumors following ovariectomy of Sprague-Dawley rats.
    Allred CD; Allred KF; Ju YH; Clausen LM; Doerge DR; Schantz SL; Korol DL; Wallig MA; Helferich WG
    Carcinogenesis; 2004 Feb; 25(2):211-8. PubMed ID: 14578162
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Estrogenic activity in white and red wine extracts.
    Klinge CM; Risinger KE; Watts MB; Beck V; Eder R; Jungbauer A
    J Agric Food Chem; 2003 Mar; 51(7):1850-7. PubMed ID: 12643641
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Promotion of estrogen-induced mammary gland carcinogenesis by androgen in the male Noble rat: probable mediation by steroid receptors.
    Liao DZ; Pantazis CG; Hou X; Li SA
    Carcinogenesis; 1998 Dec; 19(12):2173-80. PubMed ID: 9886575
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resveratrol acts as a mixed agonist/antagonist for estrogen receptors alpha and beta.
    Bowers JL; Tyulmenkov VV; Jernigan SC; Klinge CM
    Endocrinology; 2000 Oct; 141(10):3657-67. PubMed ID: 11014220
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Estradiol and progesterone can prevent rat mammary cancer when administered concomitantly with carcinogen but do not modify surviving tumor histology, estrogen receptor alpha status or Ha-ras mutation frequency.
    Swanson SM; Christov K
    Anticancer Res; 2003; 23(4):3207-13. PubMed ID: 12931682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progesterone receptor antagonism inhibits progestogen-related carcinogenesis and suppresses tumor cell proliferation.
    Lee O; Choi MR; Christov K; Ivancic D; Khan SA
    Cancer Lett; 2016 Jul; 376(2):310-7. PubMed ID: 27080304
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A ligand of peroxisome proliferator-activated receptor gamma, retinoids, and prevention of preneoplastic mammary lesions.
    Mehta RG; Williamson E; Patel MK; Koeffler HP
    J Natl Cancer Inst; 2000 Mar; 92(5):418-23. PubMed ID: 10699072
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel estrogenic action of the pesticide residue beta-hexachlorocyclohexane in human breast cancer cells.
    Steinmetz R; Young PC; Caperell-Grant A; Gize EA; Madhukar BV; Ben-Jonathan N; Bigsby RM
    Cancer Res; 1996 Dec; 56(23):5403-9. PubMed ID: 8968093
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of a new clinically relevant antiestrogen (GW5638) related to tamoxifen on breast and endometrial cancer growth in vivo.
    Dardes RC; O'Regan RM; Gajdos C; Robinson SP; Bentrem D; De Los Reyes A; Jordan VC
    Clin Cancer Res; 2002 Jun; 8(6):1995-2001. PubMed ID: 12060645
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potent inhibitory effect of a new antiestrogen (RU 16117) on the growth of 7,12-dimethylbenz[a]anthracene-induced rat mammary tumors.
    Kelly PA; Asselin J; Caron MG; Labrie F; Raynaud JP
    J Natl Cancer Inst; 1977 Mar; 58(3):623-8. PubMed ID: 402479
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 45.